AVATR was awarded the prestigious European Commission Seal of Excellence, based on the quality of the technology. With this accreditation, Inavya is well-positioned to receive fresh opportunities for AVATR. In fact, and despite challenges related to the COVID-19 pandemic, we have continued development with direct engagement of clinical teams globally.

AVATR has been selected by the Barclays Eagle Labs Accelerator, among a selected number of startups with high growth potential to join the Scale-up UK programme at the University of Cambridge’s Judge Business School.

The 6-month programme aims to enhance the performance and competitiveness of high-potential, early-stage businesses with an appetite for growth and the potential to contribute to the UK economy.

The programme is designed to support the companies by helping them formulate, articulate and implement a growth plan for their business. This includes defining and articulating the business value proposition, designing a sustainable business model, enhancing operational and leadership capabilities and strengthening financial literacy.

Aymeric Teulon, Director of Inavya, has been invited to present Avatr this week at a major international health conference: Arab Health 2020.

After four years of technical development of Avatr as an AI-enabled personalised health companion to support patients and doctors, Avatr is ready to enter the market. With the MENA region witnessing a phase of significant growth, Avatr is attracting significant interest from a range of key stakeholders in Qatar, Saudi Arabia, Bahrain and the UAE.

A recent Fitch Solutions analysis reported that the MENA region’s healthcare market is projected to grow from US$ 185.5 billion in 2019 to US$ 243.6 billion in 2023. Aymeric is due to meet a range of healthcare and government stakeholders from throughout the MENA region, with the aim to support their needs with Avatr.

Dr Jaspal Peter Sahota, an Inavya scientist, has been invited to join Lord Prior (NHS England Chairman) on a select Artificial Intelligence and Smart Diagnostics Mission to India, which will take place in New Delhi, Bengaluru and Mumbai from December 9th-13th.

India's healthcare market is anticipated to grow to USD 372bn by 2022, and innovation in healthcare delivery is a key priority for healthcare providers in the country. The UK is known for innovation and expertise in both AI and healthcare, making this the perfect opportunity to showcase the best of British AI solutions.

During the Mission, Dr Sahota - who speaks Hindi, Panjabhi and Sanskrit; and who is part of the AVATR AI technology development team - will showcase AVATR technology at a number of focused events. He will also meet with key stakeholders and influencers from the Indian healthcare industry, and meet clinicians from leading hospitals interested in deploying AVATR.

AVATR has been selected as a Global Top-50 Startup by Qatar, and has been invited to profile AVATR technology at Smart Cities Expo - Doha 2019, which starts on the 29th Oct 2019.

The international conference provides a unique opportunity for entrepreneurs, investors, innovators and professionals to achieve their ambitions, learn from the best about digital entrepreneurship, network, gain inspiration to grow their business and lead the change. Commenting on this award, Dr Michael Wilkinson said “We are delighted to be selected in the Global Top-50. This opportunity to join international startups, to network and to showcase AVATR is an important opportunity as we enter the global marketplace.”

Aymeric Teulon, Director of Inavya, received the prestigious 'Made in Dauphine' award for AVATR at an event held in Paris on 10th Oct.

Paris-Dauphine University, Dauphine Alumni, and the student and alumni association, select the "Made in Dauphine" award based on innovation excellence. Commenting on receiving the award, Aymeric noted that “The selection panel really liked AVATR. Other winners of awards were Frichti (which just raised €45m), and Madbox games (just hit over 10m downloads of their gaming platform), so AVATR is in very good company.”

The selection panel included: Yannick Bollore (CEO Havas), Bertrand Cizeau (BNP Paribas Group Head of Brand, Communications and Quality), Quentin Sannie (CEO Devialet), Pierre Chassagne (EY Partner).

Following an open competition, Inavya has been selected by the Korea Institute of Startup & Entrepreneurship Development, the Enterprise Europe Network, and the Knowledge Transfer Network as one of three promising UK Tech Startups to join the K-Ground 2019 Global Startup Exchange & Collaboration Programme.

South Korea is one of the world’s most technologically advanced and digitally connected countries. Home to global giants such as Samsung, LG, Hyundai and SK Telecom - and with major government investment in key technology areas - South Korea offers unrivalled opportunities for digital Tech Startups.

During the programme, Dr Michael Wilkinson will be immersed in the South Korean Startup ecosystem, have the opportunity to meet major companies, pitch to investors and connect with South Korean and international collaborators. The 10 Day programme will centre in Pangyo, the Silicon Valley of South Korea, from 23 September to 2nd October.

LONDON:  Deeptech Angels has selected AVATR as one of four deep technology startups to present at a pitch event on Monday 8th of July.  The event is hosted exclusively at The National Liberal Club in central London, where Dr Michael Wilkinson will pitch AVATR technology in front of validated angel investors.

PARIS: AVATR has been shortlisted for the prestigious innovation award ‘MadeInDauphine’ event at Paris Dauphine University, also on Monday 8th of July. The award recognises achievement by former alumni in innovative companies with a social impact. Members of the jury include the CEOs of Havas and Devialet, the Marketing head of Dior Couture, and the head of Unilever Africa.   Paris Dauphine Universityalumnus, Aymeric Teulon, will represent AVATR.

Dr Jaspal Peter Sahota is representing Inavya Ventures Ltd (AVATR) at the Global Leaders’ Summit - UK-India Conclave 2019. The event is a two-day exchange of enterprise, innovation and dialogue convening business leaders, investors, changemakers and entrepreneurs to enhance collaboration. Tackling critical areas of trade, investment and partnership, the event is an unmissable chance to hear from senior global leaders on the future of global India.

Dr Sahota - a Sanskrit scholar who speaks Hindi, Punjabi and Sanskrit - said “I’m delighted to have been invited. AVATR participation in the UK-India Conclave 2019 provides Inavya with unparalleled access to key stakeholders as the company prepares to extend its operations to India - one of the world’s largest and fastest growing economies.”

Dr Peter Sahota presented the Newton Fund initiative - Project CityZen - at an International Smart Cities conference in Campinas, Brazil on 5th June. The event, hosted by CPqD in Campinas, brought together leading national and international experts in the area of smart cities and advanced technologies.

Inavya is the UK lead for Project CityZen, which is a novel smart cities project taking place in Brazil using data and innovative technologies from Inavya (AVATR), Industria-I, Space Syntax and CPqD. The project takes a citizen-centred view of healthcare, using information about demographics, healthcare systems and location alongside personal experiences to create an innovative solution to help improve efficiency when deploying resources, with a special focus on care for older people.

Inavya Ventures and AVATR have been shortlisted with 5 other finalists for the Dauphine London Startup Challenge 2019 - which will take place on the 16th of May in London.

The festival, organised by Paris Dauphine University, promotes innovation and entrepreneurship led by former graduates based in the UK. As an alumni, Aymeric Teulon will be pitching AVATR against other InsurTech, Wearables, Crypto trading platforms for the title of “Most Promising Startup”.

Inavya has won a competition to research and develop its AVATR technology to benefit the National Health Service.

The Office for Life Sciences and Innovate UK, as part of UK Research and Innovation, are investing up to £1.5 million in innovation projects such as AVATR. The competition is aimed at SMEs that have developed and manufactured innovative healthtech, including medical devices, diagnostics and regulated digital healthcare products.

Dr Michael Wilkinson, CEO and Founder of Inavya, said “After several years of developing AVATR technology with clinicians in Singapore and São Paulo, we are delighted to be entering the NHS healthcare ecosystem, where we aim to deliver significant benefits to citizens and the NHS with AVATR, a CE marked medical device.”

Inavya has been selected by The Enterprise Europe Council to join the Health Valley International Event in The Netherlands on March 13, where AVATR technology will be profiled.

The aim of the event is to build international partnerships and set up innovation and research projects for Horizon 2020, Eureka/Eurostars programmes and INTERREG in the area of digital health, medical devices and personalized medicine. Represented by Inavya Director Mr Aymeric Teulon, the event will enable Inavya to expand its global network, receive advice on international grants and projects, and learn about healthcare innovations in the vibrant healthcare ecosystem of The Netherlands.

Commenting on winning this award, Inavya CEO Dr Michael Wilkinson said ‘Our growth strategy is to build a global network of AVATR hubs to serve regional markets, and then to connect these hubs globally to create synergy. We have made excellent progress in Singapore, Brazil, China and Bahrain. Looking closer to our own European market, this international event in The Netherlands brings together Europe’s leading start-ups, scale-ups, corporates, government, and universities in the area of digital health, medical devices and personalised medicine. The following countries will participate, and represent Europe’s finest network within the Life Sciences and Health sectors: The Netherlands, France, Germany, Poland, Belgium, Finland, United Kingdom, Spain and Italy.”

Astra Zeneca - China has extended an invitation to Dr Peter Sahota to present AVATR technology at the “2019 Healthcare IoT Innovation Ecosystem Summit & the 2nd Commercial Innovation Partner Conference” in Wuxi, China on March 7-8th, 2019.

With the ever increasingly clear application scenarios for the innovative and integrated “patient-centric” diagnosis and treatment solutions, AstraZeneca and partners are committed to further accelerating the cooperation into the next phase to apply Internet of Things (IoT), big data and artificial intelligence (AI) to enhance the efficiency and accessibility of healthcare service through synergising the expertise and strengths of the partners in the industrial sector.

Inavya’s Dr Peter Sahota, who is a Mandarin speaker, will present AVATR and join the 2nd CCIC Partner Conference with the theme of “Cooperation, Enhancement, and Change”. The event will be held at the Wuxi Health IoT Innovation Center, which is a global centre for healthcare innovations based in China.

AstraZeneca has invited more than 200 senior executives from more than 100 partner companies globally to attend this conference. The aim is to jointly set the overall direction and objectives of 2019, explore viable cooperation models, and work together to incubate commercial innovation models.

Today Dr Michael Wilkinson, CEO and Founder of Inavya, joined a panel of experts for the launch of the Brazil Tech Award 2019 at the Digital Catapult in London.

Brazil is home to the world’s eighth largest economy, the seventh biggest IT market, fifth largest number of mobile phone and internet users, and the third largest recipient of Foreign Direct Investment in 2017. Brazil is a strategic market for the UK Department for International Trade.

Commenting on AVATR’s Brazil opportunity, Michael said “We are actively engaged in Brazil, where we are the UK lead on Project CityZen, a Newton Fund initiative. Our AVATR technology is being developed and evaluated with clinicians from the Einstein Hospital. With a population of of over 210 million, and reach throughout Latin America, we see Brazil as a key country for scaling up and expanding AVATR internationally, connecting to our other international activities in Singapore, Bahrain and China.”

The UK government Department for International Trade has invited Inavya Ventures Ltd (AVATR) and four other UK startups to join the UK stand and participate at the UNBOUND Festival in Bahrain on 6-7 March. Aymeric Teulon, Director of Inavya Ventures Ltd, will represent the company, and strengthen the initial engagement between Inavya and the Bahrain Economic Development Board. This will go a long way to helping establish the AVATR brand locally, and hopefully lead to the implementation of a compelling demonstrator within the Middle East.

The festival will also provide a great opportunity to network with 3,000+ startups, investors and businesses, who will travel to Bahrain to hear from 100+ influential speakers, uncover pioneering ideas and take part in immersive brand experiences, hackathons, startup battles and networking sessions.

Previous Unbound events have taken place in London and Miami

Over the past week, AVATR UX design leads - John Walters and Christopher da Costa - have been engaged directly with clinicians from the Albert Einstein Hospital in São Paulo to further develop AVATR technology. The aim of these workshops is to position AVATR as a resource to support improvements in clinical outcomes and to reduce healthcare costs, as well as to improve patient experience while outside of hospital.

Our engagement with Einstein Hospital is part of Project CityZen, a smart cities Newton Fund initiative that is led by Inavya, in partnership with Future Cities Catapult and Space Syntax in the UK. Our partners in Brazil are CPqD and Industria-I.

Over the next year, new AI-enabled features will be added to AVATR to enhance user experience for doctors and patients. These features will include patient-led care plans, matchmaking the patient to local services, and voice-controlled navigation. Commenting on this Newton Fund initiative, Dr Michael Wilkinson (CEO of Inavya) said “We are excited to be working with Einstein clinicians on the further development of AVATR, and we look forward to supporting ongoing improvement in healthcare throughout our global network, which includes linked initiatives in Singapore and the EU.”

Chris & John demonstrate a prototype of AVATR to physicians at the Hospital Israelita Albert Einstein

Dr. Sahota presenting AVATR to Ping-An Insurance

AVATR continues its engagement with the China market as part of a ten-company UK delegation hosted by Innovate UK, 100%Open, China-Britain Business Council, Future Cities Catapult and Department for International Trade (DIT). The Mission started today, with Dr Peter Sahota presenting AVATR to leading officials from Ping-An Insurance Company. Dr Sahota, who is a Mandarin speaker, will next present AVATR to leading officials from Huawei.

Following meetings with additional companies and government officials from Shenzhen and Guangzhou, Dr Sahota will be attending a number of commercial meetings in Shanghai, with a view to developing strategic partnerships to enable AVATR to enter the China Market. It’s very clear from the level of interest in AVATR that China shares a pressing global challenge to control rising healthcare costs and improve clinical outcomes.

AVATR was selected for a 3-minute pitch to a panel of several representatives from the UK’s top angel investment groups (including SyndicateRoom, Nesta, Seedrs, Microsoft Accelerator, Angel Investment Network, AngelCoFund, Startup Funding Club and many more). Our pitch successfully topped 50 other startup applications and was awarded the opportunity to exhibit AVATR’s AI technology and strategy in front of the Angel Investing Hacker Panel. The competition formed part of the Business Funding Show’s Annual Investment Conference, which was held in London on the 13th of November 2018.

Aymeric Teulon and Peter Sahota were pleased today to host the investment and development delegation from the China (Fujian) Foreign Trade Center at our new Geovation office in Clerkenwell, central London.

We had the pleasure to welcome General Manager of Investment and Development, Zeng Zhiyun, and discuss the challenges around elderly care in the Fuzhou region.  We also discussed how AVATR could help as a platform as they develop a new state-of-the-art residential development for elderly citizens.